![COMPASS trial addresses the unmet need of patients with early-relapsing TNBC](https://oncodaily.com/pub/uploads/2024/06/gustaveroussy-fronton_1-e1719325393571.jpg)
Jun 27, 2024, 16:06
COMPASS trial addresses the unmet need of patients with early-relapsing TNBC
Elie Rassy,
Gustave Roussy, shared on X:“Just out… COMPASS trial, an academic study led by Gustave Roussy, Barbara Pistilli, Thomas Grinda addresses the unmet need of patients with early-relapsing TNBC by employing innovative treatment strategies.“.
Read further.
Source: Elie Rassy/X